BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10590127)

  • 1. Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses.
    Peng R; Gordadze AV; Fuentes Pananá EM; Wang F; Zong J; Hayward GS; Tan J; Ling PD
    J Virol; 2000 Jan; 74(1):379-89. PubMed ID: 10590127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus.
    Jiang H; Cho YG; Wang F
    J Virol; 2000 Jul; 74(13):5921-32. PubMed ID: 10846073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulatory properties of Epstein-Barr virus nuclear antigen 3C are conserved in simian lymphocryptoviruses.
    Zhao B; Dalbiès-Tran R; Jiang H; Ruf IK; Sample JT; Wang F; Sample CE
    J Virol; 2003 May; 77(10):5639-48. PubMed ID: 12719556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses.
    Rivailler P; Cho YG; Wang F
    J Virol; 2002 Dec; 76(23):12055-68. PubMed ID: 12414947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15).
    Fuentes-Pananá EM; Swaminathan S; Ling PD
    J Virol; 1999 Jan; 73(1):826-33. PubMed ID: 9847397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.
    Ruf IK; Moghaddam A; Wang F; Sample J
    J Virol; 1999 Mar; 73(3):1980-9. PubMed ID: 9971778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of two types of rhesus lymphocryptovirus similar to type 1 and type 2 Epstein-Barr virus.
    Cho YG; Gordadze AV; Ling PD; Wang F
    J Virol; 1999 Nov; 73(11):9206-12. PubMed ID: 10516028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2.
    Peng R; Tan J; Ling PD
    J Virol; 2000 Nov; 74(21):9953-63. PubMed ID: 11024123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus.
    Moghaddam A; Koch J; Annis B; Wang F
    J Virol; 1998 Apr; 72(4):3205-12. PubMed ID: 9525646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 function.
    McCann EM; Kelly GL; Rickinson AB; Bell AI
    J Gen Virol; 2001 Dec; 82(Pt 12):3067-3079. PubMed ID: 11714985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species-specific functions of Epstein-Barr virus nuclear antigen 2 (EBNA2) reveal dual roles for initiation and maintenance of B cell immortalization.
    Mühe J; Wang F
    PLoS Pathog; 2017 Dec; 13(12):e1006772. PubMed ID: 29261800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.
    Blake NW; Moghaddam A; Rao P; Kaur A; Glickman R; Cho YG; Marchini A; Haigh T; Johnson RP; Rickinson AB; Wang F
    J Virol; 1999 Sep; 73(9):7381-9. PubMed ID: 10438828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
    Peng R; Moses SC; Tan J; Kremmer E; Ling PD
    J Virol; 2005 Apr; 79(7):4492-505. PubMed ID: 15767449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif.
    Ling PD; Ryon JJ; Hayward SD
    J Virol; 1993 Jun; 67(6):2990-3003. PubMed ID: 8388484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
    Sjöblom A; Nerstedt A; Jansson A; Rymo L
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence analysis and variation of EBNA-1 in Epstein-Barr virus-related herpesvirus of cynomolgus monkey.
    Ohara N; Hayashi K; Teramoto N; Oka T; Fujimoto K; Yoshikawa Y; Castanos-Velez E; Biberfeld P; Akagi T
    Intervirology; 2000; 43(2):102-6. PubMed ID: 10971128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong selective pressure for evolution of an Epstein-Barr virus LMP2B homologue in the rhesus lymphocryptovirus.
    Rivailler P; Quink C; Wang F
    J Virol; 1999 Oct; 73(10):8867-72. PubMed ID: 10482645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome.
    Szymula A; Palermo RD; Bayoumy A; Groves IJ; Ba Abdullah M; Holder B; White RE
    PLoS Pathog; 2018 Feb; 14(2):e1006890. PubMed ID: 29462212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning of the rhesus lymphocryptovirus viral capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections.
    Rao P; Jiang H; Wang F
    J Clin Microbiol; 2000 Sep; 38(9):3219-25. PubMed ID: 10970361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100.
    Ling PD; Peng RS; Nakajima A; Yu JH; Tan J; Moses SM; Yang WH; Zhao B; Kieff E; Bloch KD; Bloch DB
    EMBO J; 2005 Oct; 24(20):3565-75. PubMed ID: 16177824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.